United States · Investor

ArrowMark Partners

Last cheque observed Oct 2026; 19 cheques on record.

Deploying nowNew fund $1.1B, May 2023Private equity

SeedSeries ASeries BCreditReal EstateEquity

Deploying now
100%of best year2cheques in 12 months, 19 on record
Since the last cheque2days00hrs00min00sec
Median round$93MRounds led1 of 19Mostly inUnited States, 89%
Pitch ArrowMark Partners

ArrowMark Partners highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series C and Series B: 80% of its rounds

  3. 03

    Led 1 rounds

What they do

ArrowMark Partners is a privately held, employee-owned investment management firm ... We manage assets on behalf of a broad array of institutional clients and private wealth allocators across our investment strategies.From their own website
Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
CreditReal EstateEquity
Based in
Denver, United States
Cold pitches
Not accepted

The record

Every round we can evidence, newest first19 appearances

  1. 2026

    2 rounds

  2. Oct
    Dren BioUS · Wowtale$350MWith 13 others
  3. Feb
    SkyryseSeries C · US · TechCrunch$300MWith 14 others
  4. 2024

    1 round

  5. May
    Zenas BioPharmaSeries C · US · Tellus BioVentures$200MWith 14 others
  6. 2019

    3 rounds

  7. Dec
    ArcherDxSeries C · US · FinSMEs$55MWith 8 others
  8. Aug
    ORIC PharmaceuticalsSeries D · US · Pharmanewsdaily$55MLed
  9. Apr
    SpringWorks TherapeuticsSeries B · US · FinSMEs$125MWith 12 others
  10. 2018

    10 rounds

  11. Nov
    NextCureSeries B · MD · Pehub$93MWith 12 others
  12. Sept
    Lyra TherapeuticsSeries B · US · FinSMEs$30MWith 5 others
  13. Aug
    Evolve VacationUS · FinSMEs$80MWith 5 others
  14. Aug
    Orchard TherapeuticsSeries C · GB · FinSMEs$150MWith 14 others
  15. Jul
    AscentageSeries C · US · FinSMEs$150MWith 5 others
  16. Jul
    ConveneSeries D · US · FinSMEs$152MWith 8 others
  17. Jun
    MetacrineSeries C · US · Globenewswire$65MWith 5 others
  18. Apr
    KodiakUS · FinSMEs$33MWith 1 other
  19. Mar
    TCR2Series B · US · FinSMEs$125MWith 9 others
  20. Feb
    ModernaUS · FinSMEs$500MWith 8 others
  21. 2017

    3 rounds

  22. Dec
    Neon TherapeuticsSeries B · US · FinSMEs$36MWith 8 others
  23. May
    ConveneSeries C · US · FinSMEs$68MWith 4 others
  24. Jan
    CentrexionSeries D · US · FinSMEs$67MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

RARichard Allen GroveChief Compliance OfficeriForm ADV
SSSanjai Suryaji BhonsleCEOiForm ADV

We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$224Massets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
Legal name
Arrowmark Asset Management, LLC
SEC number
CRD 307161

Who they invest alongside

The investors most often in the same rounds as ArrowMark Partners. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies ArrowMark Partners put money into.

Quick answers about ArrowMark Partners

What does ArrowMark Partners invest in?

ArrowMark Partners invests most often at Series C and Series B (80% of the rounds on record), in sectors such as Credit, Real Estate and Equity.

How active is ArrowMark Partners?

19 investments on record, 2 of them in the last 12 months, and it led 1. The most recent was in Oct 2026.

What has ArrowMark Partners invested in recently?

Its most recent investments on record: Dren Bio (Undisclosed round, Oct 2026), Skyryse (Series C, Feb 2026) and Zenas BioPharma (Series C, May 2024).

How big are ArrowMark Partners's cheques?

The median round it joins is $93M.

Does ArrowMark Partners lead rounds?

Sometimes: it led 1 of its 19 investments on record (5%).

Where does ArrowMark Partners invest?

Most of the companies it backs are in the United States (89%), Moldova (5%) and the United Kingdom (5%).

Is ArrowMark Partners investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does ArrowMark Partners invest alongside?

Most often Alexandria Real Estate Equities (3 rounds together), Fidelity (3 rounds together) and Hill House Capital (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it